Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Veltkamp

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
European Stroke Journal|April 23, 2019
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trialRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 12, 2018
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized TrialScott E Kasner, Pablo Lavados, Mukul Sharma, et al.
The New England Journal of Medicine|May 17, 2018
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined SourceRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
European Stroke Journal|January 30, 2026
Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke preventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.
Lancet (London, England)|March 1, 2025
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trialRoland Veltkamp, Eleni Korompoki, Kirsten H Harvey, et al.
The New England Journal of Medicine|April 15, 2026
Asundexian for Secondary Stroke PreventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.
Annals of Neurology|September 27, 2018
Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhageGeorgios Tsivgoulis, Duncan Wilson, Aristeidis H Katsanos, et al.
Neurology|March 12, 2024
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral MicrobleedsLuis Prats-Sanchez, Pol Camps-Renom, Philip S Nash, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 29, 2023
Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trialSven Poli, Joshua Mbroh, Jean-Claude Baron, et al.
JAMA Neurology|February 22, 2023
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral AnticoagulantsThomas R Meinel, Duncan Wilson, Henrik Gensicke, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
European Stroke Journal|April 23, 2019
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trialRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 12, 2018
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized TrialScott E Kasner, Pablo Lavados, Mukul Sharma, et al.
The New England Journal of Medicine|May 17, 2018
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined SourceRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
European Stroke Journal|January 30, 2026
Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke preventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.
Lancet (London, England)|March 1, 2025
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trialRoland Veltkamp, Eleni Korompoki, Kirsten H Harvey, et al.
The New England Journal of Medicine|April 15, 2026
Asundexian for Secondary Stroke PreventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.
Annals of Neurology|September 27, 2018
Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhageGeorgios Tsivgoulis, Duncan Wilson, Aristeidis H Katsanos, et al.
Neurology|March 12, 2024
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral MicrobleedsLuis Prats-Sanchez, Pol Camps-Renom, Philip S Nash, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 29, 2023
Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trialSven Poli, Joshua Mbroh, Jean-Claude Baron, et al.
JAMA Neurology|February 22, 2023
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral AnticoagulantsThomas R Meinel, Duncan Wilson, Henrik Gensicke, et al.
Pageof 20